Redox Proteomic Profile of Tirapazamine-Resistant Murine Hepatoma Cells.

Aušra Nemeikaitė-Čėnienė, Per Haberkant, Dalius Kučiauskas, Frank Stein, Narimantas Čėnas

Open access · goldAbstract read

In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.2field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Aušra Nemeikaitė-ČėnienėState Research Institute Center for Innovative Medicine, Santariškių St. 5, LT-08406 Vilnius, Lithuania.

Per HaberkantProteomics Core Facility EMBL Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany.ORCID 0000-0002-5608-9062

Dalius KučiauskasDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania.

Frank SteinProteomics Core Facility EMBL Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany.ORCID 0000-0001-9695-1692

Narimantas ČėnasDepartment of Xenobiotics Biochemistry, Institute of Biochemistry of Vilnius University, Saulėtekio 7, LT-10257 Vilnius, Lithuania.

European Molecular Biology Organization · DEVilnius University · LTState Research Institute Centre for Innovative Medicine · LT

Funding

European Social Fund No. DOTSUT-43/09.3.3.-LMT-K71201-0058/LSS-600000-58

6 · The paper itself

Abstract

3-Amino-1,2,4-benzotriazine-1,4-dioxide (tirapazamine, TPZ) and other heteroaromatic

Indexed as

Antineoplastic AgentsCarcinoma, HepatocellularLiver NeoplasmsAnimalsAntioxidantsGlutathione PeroxidaseMammalsMiceOxidation-ReductionProteomicsTirapazamineTriazinesAntineoplastic AgentsAntioxidantsGlutathione PeroxidaseTirapazamineTriazinescell resistancecytotoxicityoxidative stressreductive activationtirapazamine

Identifiers

PMID37047836

DOI10.3390/ijms24076863

PMCPMC10094930

OpenAlexW4362665665

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.